How to Invest in the $111 Billion Diabetes Boom (DXCM, ATRX, TNDM, MNKD, NVO, LLY)

The global diabetes market was estimated at $25.9 billion in 2020 and is expected to reach $28.5 billion in 2021 according to Grand View Research. The global market for diabetes care products including drugs and devices is even more impressive. This larger category is expected to exceed $111.2 billion by 2027 according to Why […]

MannKind Corporation (NASDAQ:MNKD) And One Drop To Strike A Collaboration To Help Diabetes Patients

MannKind Corporation (NASDAQ:MNKD) made an announcement about its collaboration with One drop revealing that they were going to engage in a randomized controlled trial. This will be in a bid to investigate the use of Afrezza inhaled insulin. One Drop’s integrated digital diabetes care platform will also be scrutinized further in an effort to identify the […]

Mannkind Corporation (NASDAQ:MNKD): Investors Can Circle April 1 On Their Calendar

Boston, MA 01/13/2013 (wallstreetpr) – That Mannkind Corporation (NASDAQ:MNKD) is becoming a pendulum is causing anxiety somewhere. There isn’t so much that one can say about this stock now except about what investors can expect in the few coming months. Of late the stock soars and pulls back without warning and there is nothing strange […]

MannKind Corporation (NASDAQ:MNKD) Hopes FDA Gives Afrezza Nod This Time

Boston, MA 10/14/2013 (wallstreetpr) –  For the sake of humanity, MannKind Corporation (NASDAQ:MNKD) which so far has no drug on the market hopes its candidate Afrezza will this time get the approval of the Food and Drug Administration (FDA).  The company on Monday announced resubmitting of new drug application to FDA for the drug candidate which […]